Mirae Asset Global Investments Co. Ltd. decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 4.5% during the third quarter, according to its most recent disclosure with the SEC. Mirae Asset Global Investments Co. Ltd.’s holdings in AstraZeneca were worth $21,525,000 at the end of the most recent quarter. HSBC reissued a “buy” rating and issued a $108.00 price objective on shares of AstraZeneca in a report on Wednesday, December 10th. TD Cowen reissued a “buy” rating on shares of AstraZeneca in a report on Tuesday, December 9th. Finally, Wall Street Zen downgraded shares of AstraZeneca from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 17th.